144 related articles for article (PubMed ID: 15220254)
1. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease.
Tai ES; Goh SY; Lee JJ; Wong MS; Heng D; Hughes K; Chew SK; Cutter J; Chew W; Gu K; Chia KS; Tan CE
Diabetes Care; 2004 Jul; 27(7):1728-34. PubMed ID: 15220254
[TBL] [Abstract][Full Text] [Related]
2. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N; Shaw J; Zimmet P; Alberti KG
Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
[TBL] [Abstract][Full Text] [Related]
3. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
4. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.
Lim SC; Tai ES; Tan BY; Chew SK; Tan CE
Diabetes Care; 2000 Mar; 23(3):278-82. PubMed ID: 10868851
[TBL] [Abstract][Full Text] [Related]
6. Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition.
Vaccaro O; Riccardi G
Diabetes Care; 2005 Jul; 28(7):1786-8. PubMed ID: 15983335
[TBL] [Abstract][Full Text] [Related]
7. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
Jadhakhan F; Marshall T; Ryan R; Gill P
BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
[TBL] [Abstract][Full Text] [Related]
8. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
[TBL] [Abstract][Full Text] [Related]
9. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
10. A1C cut points to define various glucose intolerance groups in Asian Indians.
Mohan V; Vijayachandrika V; Gokulakrishnan K; Anjana RM; Ganesan A; Weber MB; Narayan KM
Diabetes Care; 2010 Mar; 33(3):515-9. PubMed ID: 19903752
[TBL] [Abstract][Full Text] [Related]
11. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
[TBL] [Abstract][Full Text] [Related]
12. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
13. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
Shaw JE; Zimmet PZ; de Courten M; Dowse GK; Chitson P; Gareeboo H; Hemraj F; Fareed D; Tuomilehto J; Alberti KG
Diabetes Care; 1999 Mar; 22(3):399-402. PubMed ID: 10097917
[TBL] [Abstract][Full Text] [Related]
14. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
Gao W; Dong Y; Nan H; Tuomilehto J; Qiao Q
Diabetes Res Clin Pract; 2008 Jan; 79(1):151-5. PubMed ID: 17825938
[TBL] [Abstract][Full Text] [Related]
15. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.
Nóvoa FJ; Boronat M; Saavedra P; Díaz-Cremades JM; Varillas VF; La Roche F; Alberiche MP; Carrillo A
Diabetes Care; 2005 Oct; 28(10):2388-93. PubMed ID: 16186268
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population--the implications of measuring glycated hemoglobin.
Baral N; Koner BC; Karki P; Ramaprasad C; Lamsal M; Koirala S
Singapore Med J; 2000 Jun; 41(6):264-7. PubMed ID: 11109341
[TBL] [Abstract][Full Text] [Related]
19. Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.
Ko GT; Chan JC; Woo J; Cockram CS
Diabetes Care; 1998 Dec; 21(12):2094-7. PubMed ID: 9839099
[TBL] [Abstract][Full Text] [Related]
20. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
